Mitch Gold was the CEO at the helm of Alpine Immune Sciences when it was acquired for $4.9 billion by Vertex Pharmaceuticals in 2024—the highest value ever paid for a biotech company at its stage of the clinical-regulatory process. How did he do it?
Mitch joined Fenwick partners Effie Toshav and Doug Cogen for a fireside chat, kicking off Fenwick’s three-part Pathways to Success webinar series. Together, they discussed the strategies that fueled Alpine’s remarkable achievements.
Watch the full conversation here and read his key takeaways below:
Culture will drive your company’s mission. If your mission is to be a global scientific leader, let that vision be a directive for the entire team and be consistent about it. When every decision you make is in service of that mission, it builds a culture of scientific rigor and innovation that is the foundation of a strong, cohesive organization.
Build bridges with potential partners. Collaborations and partnerships can give your company the resources and recognition it needs to make that next big breakthrough. The best partnership is mutually beneficial, so be strategic about your alliances to support your long-term mission.
Be prepared for tough transitions. There are two critical transitions that occur in the biotech company lifecycle: shifting from a science-driven organization to a clinical-focused one, and later, transitioning to a commercial entity. To prepare your team to nail these changes, you need to develop strong leadership to ensure team alignment and develop flexible business strategies that can adapt to the demands of each phase. Don’t underestimate the value of a strong board of directors—and be ready to pivot on a dime.
Don’t rush to go public. The benefits of a public offering are clear—capital to fuel growth and innovation—but the challenges can make it a double-edged sword. Public offerings invite considerable regulatory scrutiny, so make sure you're prepared to deliver on the expectations that come with being under the public eye.
Invest in your regulatory team. Pharmaceutical regulation is tight, so it’s essential to have a savvy regulatory team to stay on top of evolving compliance requirements. Keep your operation running like a well-oiled machine by implementing airtight processes that let you tackle hurdles head-on and avoid costly delays.
Leapfrog from your big milestones. When you go public or achieve drug approvals, use that extra buzz to attract talent, investors, and partners to drive further growth. Seize these moments to amplify your company’s image through the smart use of media, investor relations, and public relations. Showcase your achievements and attract key stakeholders to keep your company on the path to success.
Stay up to date with our life sciences team when you subscribe to Fenwick insights.